
Nevro Corp. NVRO
Annual report 2024
added 03-04-2025
Nevro Corp. Interest Expense 2011-2026 | NVRO
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Nevro Corp.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -421 K | -586 K | 511 K | 19.7 M | 21.8 M | 10.9 M | 10.4 M | 9.9 M | 6.39 M | 2.73 M | 157 K | -654 K | 186 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.8 M | -654 K | 6.24 M |
Quarterly Interest Expense Nevro Corp.
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.01 M | 6.74 M | 6.51 M | - | 1.62 M | 1.62 M | 1.61 M | - | 1.61 M | 1.61 M | 1.6 M | - | 3.69 M | 5.7 M | 6.55 M | - | 6.36 M | 6.12 M | 2.83 M | - | 2.76 M | 2.71 M | 2.69 M | - | 2.62 M | 2.58 M | 2.56 M | - | 2.5 M | 2.45 M | 2.44 M | - | 2.38 M | 972 K | 642 K | - | 739 K | 681 K | 673 K | - | -1.27 M | 144 K | 238 K | - | 436 K | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.01 M | -1.27 M | 2.65 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | - | - | $ 162 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
624 K | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 12.89 | -9.99 % | $ 365 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 8.0 | 1.01 % | $ 1.2 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.27 | -9.29 % | $ 28 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 72.36 | -1.84 % | $ 3.95 B | ||
|
LENSAR
LNSR
|
636 K | $ 5.6 | -0.36 % | $ 67 M | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.53 | -5.56 % | $ 62.2 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 18.32 | 1.22 % | $ 430 M | ||
|
MiMedx Group
MDXG
|
-558 K | $ 3.74 | -1.06 % | $ 553 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.67 | -1.11 % | $ 382 M | ||
|
Myomo
MYO
|
-668 K | $ 1.28 | -0.78 % | $ 53.6 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
455 K | $ 37.69 | 2.64 % | $ 319 M | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 6.66 | -1.91 % | $ 201 M | ||
|
Butterfly Network
BFLY
|
2.77 M | $ 4.57 | -11.78 % | $ 1.13 B | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 10.29 | -0.48 % | $ 408 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 80.0 | - | $ 10.8 B | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 153.22 | 4.65 % | $ 10.8 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 35.16 | 0.06 % | $ 1.09 B | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.03 | -9.38 % | $ 5.63 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 41.19 | -2.31 % | $ 1.21 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 91.98 | -0.82 % | $ 3.19 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 85.96 | -1.7 % | $ 50.3 B |